Robot-assisted kidney surgery for early-stage tumors without clamping
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a robot-assisted surgery to remove part of the kidney for T1 tumors without clamping the main artery, which may help preserve kidney function. It may be an option for patients who are healthy enough for major surgery and have a small, early-stage kidney tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your kidney tumor is stage T1 (early-stage and small), confirmed by imaging scans.
- You are between 18 and 90 years old.
- You have no history of severe kidney disease or autoimmune disorders.
- Your heart and lungs are healthy enough for a major abdominal surgery.
- You are generally active and able to care for yourself (ECOG score 0 or 1).
- You are willing to have the robotic surgery without clamping the kidney artery and can give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a special technique in robot-assisted kidney surgery where the blood supply to the kidney is not clamped and the tumor is removed without sutures. It may reduce damage to healthy kidney tissue and speed recovery.
This trial tests if a 3D kidney model made with artificial intelligence helps surgeons remove a kidney tumor (partial nephrectomy) more precisely. It may help preserve healthy kidney tissue while treating the cancer.
This study compares two ways of positioning patients during robotic kidney surgery to remove a tumor. The goal is to see which position leads to better outcomes, like less pain or faster recovery.
This study tests a new, gentle way to remove small kidney tumors using a robot. The goal is to avoid cutting off blood supply to the kidney and to leave healthy tissue behind. It may help you keep more kidney function while still treating the cancer.
This trial tests a new robotic system for removing kidney tumors up to 7 cm. It aims to see if the technology helps surgeons perform partial nephrectomy (removing only the tumor) safely and effectively.
This trial compares two minimally invasive ways to remove kidney tumors—one using a robot and one using traditional small-instrument surgery (laparoscopy). The goal is to see which technique leads to better outcomes.
Hear when a new RCC, Renal Cell Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.